Soluble CD40 ligand measurement inaccuracies attributable to specimen type, processing time, and ELISA method

被引：33

作者：

Halldórsdóttir, AM

Stoker, J

Porche-Sorbet, R

Eby, CS ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Div Lab Med, St Louis, MO 63110 USA

[2] Washington Univ, Sch Med, Div Cardiol, St Louis, MO 63110 USA

来源：

CLINICAL CHEMISTRY | 2005年 / 51卷 / 06期

关键词：

D O I：

10.1373/clinchem.2005.048199

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

[No abstract available]

引用

页码：1054 / 1057

页数：4

共 10 条

[1] Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques [J].

Aggarwal, A ;

Schneider, DJ ;

Terrien, EF ;

Sobel, BE ;

Dauerman, HL .

AMERICAN JOURNAL OF CARDIOLOGY, 2004, 93 (01) :6-9

[2] Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina -: Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes [J].

Aukrust, P ;

Müller, F ;

Ueland, T ;

Berget, T ;

Aaser, E ;

Brunsvig, A ;

Solum, NO ;

Forfang, K ;

Froland, SS ;

Gullestad, L .

CIRCULATION, 1999, 100 (06) :614-620

[3] Soluble CD40 ligand in acute coronary syndromes [J].

Heeschen, C ;

Dimmeler, S ;

Hamm, CW ;

van den Brand, MJ ;

Boersma, E ;

Zeiher, AM ;

Simoons, ML ;

CAPTURE Study Investigators .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (12) :1104-1111

[4]

JINCHUAN Y, 2003, CLIN CHIM ACTA, V339, P85

[5] Cardiopulmonary bypass induces release of soluble CD40 ligand [J].

Nannizzi-Alaimo, L ;

Rubenstein, MH ;

Alves, VL ;

Leong, GY ;

Phillips, DR ;

Gold, HK .

CIRCULATION, 2002, 105 (24) :2849-2854

[6] Soluble CD40L and cardiovascular risk in women [J].

Schönbeck, U ;

Varo, N ;

Libby, P ;

Buring, J ;

Ridker, PM .

CIRCULATION, 2001, 104 (19) :2266-2268

[7] Measurement of soluble P-selectin and soluble CD40 ligand in serum and plasma [J].

Thom, J ;

Gilmore, G ;

Yi, Q ;

Hankey, GJ ;

Eikelboom, JW .

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2004, 2 (11) :2067-2069

[8] Soluble CD40L -: Risk prediction after acute coronary syndromes [J].

Varo, N ;

de Lemos, JA ;

Libby, P ;

Morrow, DA ;

Murphy, SA ;

Nuzzo, R ;

Gibson, CM ;

Cannon, CP ;

Braunwald, E ;

Schönbeck, U .

CIRCULATION, 2003, 108 (09) :1049-1052

[9] Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis [J].

Viallard, JF ;

Solanilla, A ;

Gauthier, B ;

Contin, C ;

Déchanet, J ;

Grosset, C ;

Moreau, JF ;

Praloran, V ;

Nurden, P ;

Pellegrin, JL ;

Nurden, AT ;

Ripoche, J .

BLOOD, 2002, 99 (07) :2612-2614

[10] The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes [J].

Yan, JC ;

Zhu, H ;

Gao, L ;

Wu, ZG ;

Kong, XT ;

Zon, RQ ;

Zhan, LZ .

CLINICA CHIMICA ACTA, 2004, 343 (1-2) :155-159

← 1 →